**Core Concept**
Botulinum toxin inhibits acetylcholine release at the neuromuscular junction by blocking the fusion of synaptic vesicles with the presynaptic membrane. It does not act directly on the central nervous system (CNS), nor does it interfere with autonomic neurotransmission at ganglionic levels.

**Why the Correct Answer is Right**
Botulinum toxin specifically targets the **presynaptic terminal** of motor neurons at the **neuromuscular junction**, preventing acetylcholine release. It also affects **autonomic post-ganglionic neurons** (e.g., in sweat glands and smooth muscles) by inhibiting neurotransmitter release at the post-ganglionic synapse. However, it **does not act on preganglionic neurons** or the **central nervous system**, as it does not cross the blood-brain barrier or interfere with CNS neurotransmission.

**Why Each Wrong Option is Incorrect**
Option A: Botulinum toxin directly acts at the neuromuscular junction by inhibiting acetylcholine release.
Option B: Preganglionic junctions (e.g., in autonomic ganglia) are affected because botulinum toxin inhibits neurotransmitter release from presynaptic terminals.
Option C: Post-ganglionic nerves are impacted, especially in sweat glands and blood vessels, due to reduced acetylcholine release.
Option D: This is the correct answer — botulinum toxin **does not affect the CNS**; it acts only at peripheral synapses.

**Clinical Pearl / High-Yield Fact**
Botulinum toxin acts **peripherally**, not centrally — it does not cross the blood-brain barrier or affect CNS neurotransmission. This makes it safe for use in treating muscle spasticity and dystonia without central side effects.

✓ Correct Answer: D. CNS